User profiles for Robert Szulcek

Robert Szulcek

Charité - Universitätsmedizin Berlin
Verified email at charite.de
Cited by 1362

Electric cell-substrate impedance sensing for the quantification of endothelial proliferation, barrier function, and motility

R Szulcek, HJ Bogaard… - JoVE (Journal of …, 2014 - jove.com
Electric Cell-substrate Impedance Sensing (ECIS) is an in vitro impedance measuring system
to quantify the behavior of cells within adherent cell layers. To this end, cells are grown in …

Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension

…, O Boucherat, GPL Bossers, R Szulcek… - American journal of …, 2019 - atsjournals.org
Rationale: Pulmonary arterial hypertension (PAH) is a degenerative arteriopathy that leads
to right ventricular (RV) failure. BRD4 (bromodomain-containing protein 4), a member of the …

Delayed microvascular shear adaptation in pulmonary arterial hypertension. Role of platelet endothelial cell adhesion molecule-1 cleavage

R Szulcek, CM Happe, N Rol, RD Fontijn… - American journal of …, 2016 - atsjournals.org
Rationale: Altered pulmonary hemodynamics and fluid flow–induced high shear stress (HSS)
are characteristic hallmarks in the pathogenesis of pulmonary arterial hypertension (PAH). …

Contribution of impaired parasympathetic activity to right ventricular dysfunction and pulmonary vascular remodeling in pulmonary arterial hypertension

…, XQ Sun, KR Casali, AG Casali, N Rol, R Szulcek… - Circulation, 2018 - Am Heart Assoc
Background: The beneficial effects of parasympathetic stimulation have been reported in left
heart failure, but whether it would be beneficial for pulmonary arterial hypertension (PAH) …

Cellular senescence impairs the reversibility of pulmonary arterial hypertension

…, JR Moonen, K Kurakula, R Szulcek… - Science Translational …, 2020 - science.org
Pulmonary arterial hypertension (PAH) in congenital cardiac shunts can be reversed by
hemodynamic unloading (HU) through shunt closure. However, this reversibility potential is lost …

[HTML][HTML] Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

…, B Qazi-Chaudhry, AJ Ainscough, R Szulcek… - Nature …, 2020 - nature.com
Pulmonary arterial hypertension (PAH) is a severe disorder of lung vasculature that causes
right heart failure. Homoeostatic effects of flow-activated transcription factor Krüppel-like …

Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity

R Szulcek, CML Beckers, J Hodzic… - Cardiovascular …, 2013 - academic.oup.com
Aims Endothelial cells (ECs) control vascular permeability by forming a monolayer that is
sealed by extracellular junctions. Various mediators modulate the endothelial barrier by acting …

Epigenetic modification of the von Willebrand factor promoter drives platelet aggregation on the pulmonary endothelium in chronic thromboembolic pulmonary …

XD Manz, R Szulcek, X Pan, P Symersky… - American journal of …, 2022 - atsjournals.org
Rationale: von Willebrand factor (vWF) mediates platelet adhesion during thrombosis. While
chronic thromboembolic pulmonary hypertension (CTEPH) is associated with increased …

[HTML][HTML] Extracellular matrix protein ratios in the human heart and vessels: how to distinguish pathological from physiological changes?

C Wittig, R Szulcek - Frontiers in Physiology, 2021 - frontiersin.org
Cardiovascular pathology is often accompanied by changes in relative content and/or ratios
of structural extracellular matrix (ECM) proteins within the heart and elastic vessels. Three of …

Nitrosation-dependent caveolin 1 phosphorylation, ubiquitination, and degradation and its association with idiopathic pulmonary arterial hypertension

…, T Sharma, WM Elliott, R Szulcek… - Pulmonary …, 2013 - journals.sagepub.com
In the present study, we tested the hypothesis that chronic inflammation and oxidative/nitrosative
stress induce caveolin 1 (Cav-1) degradation, providing an underlying mechanism of …